Solubility Enhancement of Budesonide and Statistical Optimization of Coating Variables for Targeted Drug Delivery

Table 14

In vitro drug release study of HB1 after stability.

Time (hours)	% Drug release (mean ± S.D.)
	0 month	1 month	2 month	3 month
1	1.64±0.59	2.01±0.20	1.12±0.78	2.91±0.89
2	4.64±1.30	3.94±0.25	3.98±0.33	4.98±0.78
3	4.68±1.30	3.94±0.25	3.98±0.33	4.98±0.78
4	4.68±1.30	3.94±0.25	3.98±0.33	4.98±0.78
5	17.40±1.66	17.72±0.43	18.78±1.21	19.12±1.45
6	31.16±0.51	33.81±1.22	33.67±1.89	32.49±1.56
7	48.11±0.65	48.54±0.89	49.09±0.63	49.94±0.98
8	76.24±0.80	75.81±0.98	78.11±1.12	79.42±0.92
9	88.19±2.79	88.47±2.18	90.41±1.97	91.75±2.22
10	100.36±0.87	100.98±0.76	101.72±1.12	101.12±1.59